By Professor Ric Day

Journal articles

Baysari MT; Westbrook JI; Richardson K; Day RO, 2014, 'Optimising computerised alerts within electronic medication management systems: A synthesis of four years of research', Studies in Health Technology and Informatics, 204, pp. 1 - 6, http://dx.doi.org/10.3233/978-1-61499-427-5-1

Fransen M; Day RO, 2014, 'Response to A. G. Helg's comments on the LEGS study', Annals of the Rheumatic Diseases, 73, http://dx.doi.org/10.1136/annrheumdis-2014-205569

Williams CM; Maher CG; Latimer J; McLachlan AJ; Hancock MJ; Day RO; Lin C-WC, 2014, 'Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial', The Lancet, 384, pp. 1586 - 1596, http://dx.doi.org/10.1016/S0140-6736(14)60805-9

Kannangara DRW; Ramasamy SN; Ray JE; Jones G; Graham GG; Williams KM; Day RO, 2013, 'An audit of a therapeutic drug monitoring service for allopurinol therapy', Therapeutic Drug Monitoring, 35, pp. 863 - 866, http://dx.doi.org/10.1097/FTD.0b013e318299920a

Baysari MT; Oliver K; Egan B; Li L; Richardson K; Sandaradura I; Westbrook JI; Day RO, 2013, 'Audit and feedback of antibiotic use', Applied Clinical Informatics, 4, pp. 583 - 595, http://dx.doi.org/10.4338/ACI-2013-08-RA-0063

Arabadzhiyska PN; Baysari MT; Walter S; Day RO; Westbrook JI, 2013, 'Shedding light on junior doctors' work practices after hours', Internal Medicine Journal, 43, pp. 1321 - 1326, http://dx.doi.org/10.1111/imj.12223

Day RO; Graham GG, 2013, 'Republished research: Non-steroidal anti-inflammatory drugs (NSAIDs)', British Journal of Sports Medicine, 47, pp. 1127, http://dx.doi.org/10.1136/bjsports-2013-f3195rep

Westbrook JI; Baysari MT; Li L; Burke R; Richardson KL; Day RO, 2013, 'The safety of electronic prescribing: Manifestations, mechanisms, and rates of system-related errors associated with two commercial systems in hospitals', Journal of the American Medical Informatics Association, 20, pp. 1159 - 1167, http://dx.doi.org/10.1136/amiajnl-2013-001745

Lewis JRR; Lipworth WL; Kerridge IH; Day RO, 2013, 'The economic evaluation of personalised oncology medicines: Ethical challenges', Medical Journal of Australia, 199, pp. 471 - 473, http://dx.doi.org/10.5694/mja13.10046

Ramasamy SN; Korb-Wells CS; Kannangara DRW; Smith MWH; Wang N; Roberts DM; Graham GG; Williams KM; Day RO, 2013, 'Allopurinol hypersensitivity: A systematic review of all published cases, 1950-2012', Drug Safety, 36, pp. 953 - 980, http://dx.doi.org/10.1007/s40264-013-0084-0

Tea CK; Baysari MT; Day RO, 2013, 'Compliance with antibiotic prescribing policy: Perspectives of policymakers and prescribers', Australian Journal of Pharmacy, 94, pp. 74 - 77

Day R; Lee H; Graham G; Williams K, 2013, 'Benzbromarone: Availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt on benzbromarone)', New Zealand Medical Journal, 126, pp. 124 - 126

Williams CM; Maher CG; Latimer J; McLachlan AJ; Hancock MJ; Day RO; Billot L; Lin CWC, 2013, 'PACE - the first placebo controlled trial of paracetamol for acute low back pain: Statistical analysis plan', Trials, 14, http://dx.doi.org/10.1186/1745-6215-14-248

Baysari M; Day R; Teo CK, 2013, 'Understanding compliance to an antibiotic prescribing policy: Perspectives of policymakers and prescribers', Journal of Pharmacy Practice and Research, 43, pp. 32 - 36

Missiakos O; Baysari MT; Day RO, 2013, 'Identifying effective strategies to prevent drug-drug interactions in hospital: A user-centered approach', 49th Annual Human Factors and Ergonomics Society of Australia Conference 2013, HFESA 2013

Day R, 2013, 'Off-label prescribing', Australian Prescriber, 36, pp. 182 - 183, http://dx.doi.org/10.18773/austprescr.2013.075

Carmichael SJ; Day RO; Tett S, 2013, 'A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus', Internal Medicine Journal, 43, pp. 547 - 553, http://dx.doi.org/10.1111/imj.12100

Brett J; Chong O; Graham GG; Ray J; Marriott D; Williams KM; Day RO, 2013, 'Antifungal Use and Therapeutic Monitoring of Plasma Concentrations of Itraconazole in Heart and Lung Transplantation Patients.', Therapeutic Drug Monitoring, 35, pp. 133 - 136, http://dx.doi.org/10.1097/FTD.0b013e318275fe69

Wong C; Kumar SS; Graham GG; Begg EJ; Chin P; Brett J; Ray J; Marriott D; Williams KM; Day RO, 2013, 'Comparing dose prediction software used to manage gentamicin dosing', Internal Medicine Journal, 43, pp. 519 - 525, http://dx.doi.org/10.1111/imj.12067

Lee P; Day RO; Greenfield JR; Ho KK, 2013, 'Formoterol, a highly selective beta 2-selective agonist, increases energy expenditure and fat utilisation in men', International journal of obesity, 37, pp. 593 - 597, http://dx.doi.org/10.1038/ijo.2012.90

Lipworth WL; Kerridge IH; Day RO, 2013, 'Formulating an ethics agenda for drug development, regulation, and utilization', Therapeutic Innovation & Regulatory Science, 47, pp. 46 - 49, http://dx.doi.org/10.1177/2168479012469949

Lee M-H; Stocker S; Williams KM; Day RO, 2013, 'HLA-B*5801 should be used to screen for risk of Stevens-Johnson Syndrome (SJS) in family members of Han-Chinese patients commencing allopurinol therapy', Journal of Rheumatology, 40, pp. 96 - 97, http://dx.doi.org/10.3899/jrheum.120803

Wiley J; Westbrook M; Long J; Greenfield JR; Day RO; Braithwaite J, 2013, 'Multidisciplinary diabetes team care: The experiences of young adults with Type 1 diabetes', Health Expectations, http://dx.doi.org/10.1111/hex.12170

Day RO; Graham GG, 2013, 'Non-steroidal anti-inflammatory drugs (NSAIDs)', BMJ, 346, pp. Article No. f3195, http://dx.doi.org/10.1136/bmj.f3195

Ghinea N; Lipworth W; Little M; Kerridge I; Day R, 2013, 'Overcoming Entrenched Disagreements: the Case of Misoprostol for Post-Partum Haemorrhage', Developing World Bioethics, pp. n/a - n/a, http://dx.doi.org/10.1111/dewb.12040

Duong JK; Kumar SS; Carl m kirkpatrick CM; Greenup LC; Arora M; Lee TC; Timmins P; Graham GG; Furlong TJ; Greenfield JR; Williams KM; Day RO, 2013, 'Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes: Simulation of doses according to renal function', Clinical Pharmacokinetics, 52, pp. 373 - 384, http://dx.doi.org/10.1007/s40262-013-0046-9

Harris IA; Day RO, 2013, 'PRECISE - pregabalin in addition to usual care for sciatica: study protocol for a randomised controlled trial', Trials, 14, pp. 213, http://dx.doi.org/10.1186/1745-6215-14-213

Gallego B; Runciman WB; Perez-Concha O; Liaw S; Day RO; Dunn AG; Coiera E; Liaw T, 2013, 'The management of severe hypertension in Australian general practice', BMC health services research, 13, pp. 414, http://dx.doi.org/10.1186/1472-6963-13-414

Graham GG; Davies MJ; Day RO; Mohamudally A; Scott KF, 2013, 'The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.', Inflammopharmacology, 21, pp. 201 - 232, http://dx.doi.org/10.1007/s10787-013-0172-x

Day RO; Kannangara DRW; Hayes JM; Furlong TJ, 2012, 'Successful use of allopurinol in a patient on dialysis.', BMJ case reports, 2012

Runciman WB; Hunt TD; Hannaford NA; Hibbert PD; Westbrook JI; Coiera EW; Day RO; Hindmarsh DM; McGlynn EA; Braithwaite J, 2012, 'CareTrack: assessing the appropriateness of health care delivery in Australia REPLY', MEDICAL JOURNAL OF AUSTRALIA, 197, pp. 549 - 550, http://dx.doi.org/10.5694/mja12.11210

Hunt T; Ramanathan S; Hannaford N; Hibbert P; Braithwaite J; Coiera E; Day RO; Westbrook J; Runciman W, 2012, 'CareTrack Australia: assessing the appropriateness of adult healthcare: Protocol for a retrospective medical record review', BMJ Open, 2, pp. 665, http://dx.doi.org/10.1136/bmjopen-2011-000665

Runciman W; Hunt T; Hannaford N; Hibbert P; Westbrook J; Coiera E; Hindmarsh D; Day RO; Mcglynn EA; Braithwaite J, 2012, 'CareTrack: Assessing the appropriateness of health care delivery in Australia', Medical Journal of Australia, 197, pp. 100 - 105, http://dx.doi.org/10.5694/mja12.10510

Baysari MT; Day RO; Westbrook J, 2012, 'Consistency or efficiency? A dilemma for designers', Journal of the American Medical Informatics Association, 19, pp. 1119 - 1120, http://dx.doi.org/10.1136/amiajnl-2012-001254

Lipworth WL; Ho K; Kerridge IH; Day RO, 2012, 'Drug policy at the margins: The case of growth hormone replacement for adults with severe growth hormone deficiency', Medical Journal of Australia, 197, pp. 204 - 205, http://dx.doi.org/10.5694/mja11.11572

Westbrook J; Reckmann M; Li L; Runciman W; Burke R; Lo C; Baysari MT; Braithwaite J; Day RO, 2012, 'Effects of two commercial electronic prescribing systems on prescribing error rates in hospital inpatients: a before and after study', PLOS Medicine, 9, pp. e1001164, http://dx.doi.org/10.1371/journal.pmed.1001164

Lipworth WL; Kerridge IH; Little M; Day RO, 2012, 'Evidence and desperation in off-label prescribing: Recombinant factor VIIa', British Medical Journal: International, 344, pp. d7926, http://dx.doi.org/10.1136/bmj.d7926

Baysari MT; Reckmann M; Li L; Day RO; Westbrook J, 2012, 'Failure to utilize functions of an electronic prescribing system and the subsequent generation of 'technically preventable' computerized alerts', Journal of the American Medical Informatics Association, 19, pp. 1003 - 1010, http://dx.doi.org/10.1136/amiajnl-2011-000730

Kannangara DRW; Ramasamy SN; Indraratna P; Stocker S; Graham GG; Jones G; Portek I; Williams KM; Day RO, 2012, 'Fractional clearance of urate: Validation of measurement in spot urine samples in healthy subjects and gouty patients', Arthritis Research and Therapy, 14, pp. R189 - R197, http://dx.doi.org/10.1186/ar4020

Baysari MT; Tang T; Brett J; Day RO, 2012, 'Implementation of revised aminoglycoside guidelines: Australian hospitals 'left in the lurch'', Journal of Pharmacy Practice and Research, 42, pp. 178 - 179

Lee M-H; Stocker S; Anderson JM; Phillips EJ; Nolan DL; Williams KM; Graham GG; Sullivan JR; Day RO, 2012, 'Initiating allopurinol therapy: Do we need to know the patient's human leucocyte antigen status?', Internal Medicine Journal, 42, pp. 411 - 416, http://dx.doi.org/10.1111/j.1445-5994.2011.02567.x

Dunn AG; Day RO; Mandl K; Coiera E, 2012, 'Learning from Hackers: Open-Source Clinical Trials', Science Translational Medicine, 4, pp. 132cm5, http://stm.sciencemag.org/cgi/rapidpdf/4/132/132cm5?ijkey=r6Ku/MbAUiQyE&keytype=ref&siteid=scitransmed

Duong JK; Roberts DM; Furlong TJ; Kumar SS; Greenfield JR; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2012, 'Metformin therapy in patients with chronic kidney disease', Diabetes Obesity and Metabolism, 14, pp. 963 - 965, http://dx.doi.org/10.1111/j.1463-1326.2012.01617.x

Dunn AG; Braithwaite J; Gallego B; Day RO; Runciman W; Coiera E, 2012, 'Nation-scale adoption of new medicines by doctors: an application of the Bass diffusion model', BMC health services research, 12, pp. 248 - 248, http://dx.doi.org/10.1186/1472-6963-12-248

Ghinea N; Lipworth WL; Kerridge IH; Day RO, 2012, 'No evidence or no alternative? Taking responsibility for off-label prescribing', Internal Medicine Journal, 42, pp. 247 - 251, http://dx.doi.org/10.1111/j.1445-5994.2012.02713.x

Kannangara D; Roberts DM; Furlong TJ; Graham GG; Williams K; Day RO, 2012, 'Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease', British Journal of Clinical Pharmacology, 73, pp. 828 - 829, http://dx.doi.org/10.1111/j.1365-2125.2011.04147.x

Day RO; Kannangara DRW; Hayes JM; Furlong TJ, 2012, 'Successful use of allopurinol in a patient on dialysis', BMJ Case Reports, 2012, pp. 1 - 3, http://dx.doi.org/10.1136/bcr.02.2012.5814

Stocker S; Mclachlan AJ; Savic RM; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2012, 'The pharmacokinetics of oxypurinol in people with gout', British Journal of Clinical Pharacology, 74, pp. 477 - 489, http://dx.doi.org/10.1111/j.1365-2125.2012.04207.x

Dunn AG; Bourgeois F; Murthy S; Mandl K; Day RO; Coiera E, 2012, 'The role and impact of research agendas on the comparative effectiveness research amongst anti-hyperlipidemics', Clinical Pharmacology and Therapeutics, 91, pp. 685 - 691, http://dx.doi.org/10.1038/clpt.2011.279

Lipworth WL; Kerridge IH; Day RO, 2012, 'Time for the Pharmaceutical Benefits Advisory Committee to set its own agenda', Medical Journal of Australia, 196, pp. 374 - 375

Back to profile page